BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15466698)

  • 1. Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation.
    Hayashi T; Su TP
    Proc Natl Acad Sci U S A; 2004 Oct; 101(41):14949-54. PubMed ID: 15466698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detergent-resistant microdomains determine the localization of sigma-1 receptors to the endoplasmic reticulum-mitochondria junction.
    Hayashi T; Fujimoto M
    Mol Pharmacol; 2010 Apr; 77(4):517-28. PubMed ID: 20053954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sigma-1 receptors (sigma(1) binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export.
    Hayashi T; Su TP
    J Pharmacol Exp Ther; 2003 Aug; 306(2):718-25. PubMed ID: 12730355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sigma-1 receptors regulate hippocampal dendritic spine formation via a free radical-sensitive mechanism involving Rac1xGTP pathway.
    Tsai SY; Hayashi T; Harvey BK; Wang Y; Wu WW; Shen RF; Zhang Y; Becker KG; Hoffer BJ; Su TP
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22468-73. PubMed ID: 20018732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sigma-1 receptors regulate Bcl-2 expression by reactive oxygen species-dependent transcriptional regulation of nuclear factor kappaB.
    Meunier J; Hayashi T
    J Pharmacol Exp Ther; 2010 Feb; 332(2):388-97. PubMed ID: 19855099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sigma-1 receptor: roles in neuronal plasticity and disease.
    Kourrich S; Su TP; Fujimoto M; Bonci A
    Trends Neurosci; 2012 Dec; 35(12):762-71. PubMed ID: 23102998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase A activation down-regulates, whereas extracellular signal-regulated kinase activation up-regulates sigma-1 receptors in B-104 cells: Implication for neuroplasticity.
    Cormaci G; Mori T; Hayashi T; Su TP
    J Pharmacol Exp Ther; 2007 Jan; 320(1):202-10. PubMed ID: 17050780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lifetime of UDP-galactose:ceramide galactosyltransferase is controlled by a distinct endoplasmic reticulum-associated degradation (ERAD) regulated by sigma-1 receptor chaperones.
    Hayashi T; Hayashi E; Fujimoto M; Sprong H; Su TP
    J Biol Chem; 2012 Dec; 287(51):43156-69. PubMed ID: 23105111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma-1Rs are upregulated via PERK/eIF2α/ATF4 pathway and execute protective function in ER stress.
    Mitsuda T; Omi T; Tanimukai H; Sakagami Y; Tagami S; Okochi M; Kudo T; Takeda M
    Biochem Biophys Res Commun; 2011 Nov; 415(3):519-25. PubMed ID: 22079628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.
    Fujimoto M; Hayashi T; Urfer R; Mita S; Su TP
    Synapse; 2012 Jul; 66(7):630-9. PubMed ID: 22337473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of sigma-1 receptors in lipid transport and lipid raft reconstitution in the brain: implication for drug abuse.
    Hayashi T; Su TP
    Life Sci; 2005 Aug; 77(14):1612-24. PubMed ID: 16002098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution.
    Takebayashi M; Hayashi T; Su TP
    Synapse; 2004 Aug; 53(2):90-103. PubMed ID: 15170821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular dynamics of sigma-1 receptors (sigma(1) binding sites) in NG108-15 cells.
    Hayashi T; Su TP
    J Pharmacol Exp Ther; 2003 Aug; 306(2):726-33. PubMed ID: 12730356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sigma-1 receptor chaperone as an inter-organelle signaling modulator.
    Su TP; Hayashi T; Maurice T; Buch S; Ruoho AE
    Trends Pharmacol Sci; 2010 Dec; 31(12):557-66. PubMed ID: 20869780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLN3p impacts galactosylceramide transport, raft morphology, and lipid content.
    Rusyn E; Mousallem T; Persaud-Sawin DA; Miller S; Boustany RM
    Pediatr Res; 2008 Jun; 63(6):625-31. PubMed ID: 18317235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compromising σ-1 receptors at the endoplasmic reticulum render cytotoxicity to physiologically relevant concentrations of dopamine in a nuclear factor-κB/Bcl-2-dependent mechanism: potential relevance to Parkinson's disease.
    Mori T; Hayashi T; Su TP
    J Pharmacol Exp Ther; 2012 Jun; 341(3):663-71. PubMed ID: 22399814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of the sigma-1 receptor in neurodegeneration and neurorestoration.
    Ruscher K; Wieloch T
    J Pharmacol Sci; 2015 Jan; 127(1):30-5. PubMed ID: 25704015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes.
    Gebreselassie D; Bowen WD
    Eur J Pharmacol; 2004 Jun; 493(1-3):19-28. PubMed ID: 15189760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glycolipids in lipid rafts: a view through atomistic molecular dynamics simulations with galactosylceramide.
    Hall A; Róg T; Karttunen M; Vattulainen I
    J Phys Chem B; 2010 Jun; 114(23):7797-807. PubMed ID: 20496924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sigma-1 receptor chaperones at the ER-mitochondrion interface regulate Ca(2+) signaling and cell survival.
    Hayashi T; Su TP
    Cell; 2007 Nov; 131(3):596-610. PubMed ID: 17981125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.